Global Temporal Arteritis Market Growth 2026-2032
The global Temporal Arteritis market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.
United States market for Temporal Arteritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Temporal Arteritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Temporal Arteritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Temporal Arteritis players cover Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Temporal Arteritis Industry Forecast? looks at past sales and reviews total world Temporal Arteritis sales in 2025, providing a comprehensive analysis by region and market sector of projected Temporal Arteritis sales for 2026 through 2032. With Temporal Arteritis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Temporal Arteritis industry.
This Insight Report provides a comprehensive analysis of the global Temporal Arteritis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Temporal Arteritis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Temporal Arteritis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Temporal Arteritis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Temporal Arteritis.
This report presents a comprehensive overview, market shares, and growth opportunities of Temporal Arteritis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.
United States market for Temporal Arteritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Temporal Arteritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Temporal Arteritis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Temporal Arteritis players cover Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Temporal Arteritis Industry Forecast? looks at past sales and reviews total world Temporal Arteritis sales in 2025, providing a comprehensive analysis by region and market sector of projected Temporal Arteritis sales for 2026 through 2032. With Temporal Arteritis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Temporal Arteritis industry.
This Insight Report provides a comprehensive analysis of the global Temporal Arteritis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Temporal Arteritis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Temporal Arteritis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Temporal Arteritis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Temporal Arteritis.
This report presents a comprehensive overview, market shares, and growth opportunities of Temporal Arteritis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Parenteral
- Hospital
- Home Care
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis AG
- Endo International Inc
- Teva Pharmaceutical Industries Ltd
- Glenmark Pharmaceuticals Ltd
- Cipla Inc
- Dr Reddy's Laboratories Ltd
- Abbott
- F. Hoffmann -La Roche Ltd
- Pfizer Inc
- Zydus Group
- Lupin
- Amorphex Therapeutics Holdings, Inc
- Bausch Health Companies Inc
- Regeneron Pharmaceuticals Inc
- Astellas Pharma Inc
- What is the 10-year outlook for the global Temporal Arteritis market?
- What factors are driving Temporal Arteritis market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Temporal Arteritis market opportunities vary by end market size?
- How does Temporal Arteritis break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Temporal Arteritis Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Temporal Arteritis by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Temporal Arteritis by Country/Region, 2021, 2025 & 2032
2.2 Temporal Arteritis Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.2.3 Temporal Arteritis Sales by Type
2.2.3.1 Global Temporal Arteritis Sales Market Share by Type (2021-2026)
2.2.3.2 Global Temporal Arteritis Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Temporal Arteritis Sale Price by Type (2021-2026)
2.3 Temporal Arteritis Segment by Application
2.3.1 Hospital
2.3.2 Home Care
2.3.3 Other
2.3.4 Temporal Arteritis Sales by Application
2.3.4.1 Global Temporal Arteritis Sale Market Share by Application (2021-2026)
2.3.4.2 Global Temporal Arteritis Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Temporal Arteritis Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Temporal Arteritis Breakdown Data by Company
3.1.1 Global Temporal Arteritis Annual Sales by Company (2021-2026)
3.1.2 Global Temporal Arteritis Sales Market Share by Company (2021-2026)
3.2 Global Temporal Arteritis Annual Revenue by Company (2021-2026)
3.2.1 Global Temporal Arteritis Revenue by Company (2021-2026)
3.2.2 Global Temporal Arteritis Revenue Market Share by Company (2021-2026)
3.3 Global Temporal Arteritis Sale Price by Company
3.4 Key Manufacturers Temporal Arteritis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Temporal Arteritis Product Location Distribution
3.4.2 Players Temporal Arteritis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TEMPORAL ARTERITIS BY GEOGRAPHIC REGION
4.1 World Historic Temporal Arteritis Market Size by Geographic Region (2021-2026)
4.1.1 Global Temporal Arteritis Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Temporal Arteritis Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Temporal Arteritis Market Size by Country/Region (2021-2026)
4.2.1 Global Temporal Arteritis Annual Sales by Country/Region (2021-2026)
4.2.2 Global Temporal Arteritis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Temporal Arteritis Sales Growth
4.4 APAC Temporal Arteritis Sales Growth
4.5 Europe Temporal Arteritis Sales Growth
4.6 Middle East & Africa Temporal Arteritis Sales Growth
5 AMERICAS
5.1 Americas Temporal Arteritis Sales by Country
5.1.1 Americas Temporal Arteritis Sales by Country (2021-2026)
5.1.2 Americas Temporal Arteritis Revenue by Country (2021-2026)
5.2 Americas Temporal Arteritis Sales by Type (2021-2026)
5.3 Americas Temporal Arteritis Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Temporal Arteritis Sales by Region
6.1.1 APAC Temporal Arteritis Sales by Region (2021-2026)
6.1.2 APAC Temporal Arteritis Revenue by Region (2021-2026)
6.2 APAC Temporal Arteritis Sales by Type (2021-2026)
6.3 APAC Temporal Arteritis Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Temporal Arteritis by Country
7.1.1 Europe Temporal Arteritis Sales by Country (2021-2026)
7.1.2 Europe Temporal Arteritis Revenue by Country (2021-2026)
7.2 Europe Temporal Arteritis Sales by Type (2021-2026)
7.3 Europe Temporal Arteritis Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Temporal Arteritis by Country
8.1.1 Middle East & Africa Temporal Arteritis Sales by Country (2021-2026)
8.1.2 Middle East & Africa Temporal Arteritis Revenue by Country (2021-2026)
8.2 Middle East & Africa Temporal Arteritis Sales by Type (2021-2026)
8.3 Middle East & Africa Temporal Arteritis Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Temporal Arteritis
10.3 Manufacturing Process Analysis of Temporal Arteritis
10.4 Industry Chain Structure of Temporal Arteritis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Temporal Arteritis Distributors
11.3 Temporal Arteritis Customer
12 WORLD FORECAST REVIEW FOR TEMPORAL ARTERITIS BY GEOGRAPHIC REGION
12.1 Global Temporal Arteritis Market Size Forecast by Region
12.1.1 Global Temporal Arteritis Forecast by Region (2027-2032)
12.1.2 Global Temporal Arteritis Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Temporal Arteritis Forecast by Type (2027-2032)
12.7 Global Temporal Arteritis Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Temporal Arteritis Product Portfolios and Specifications
13.1.3 Novartis AG Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Endo International Inc
13.2.1 Endo International Inc Company Information
13.2.2 Endo International Inc Temporal Arteritis Product Portfolios and Specifications
13.2.3 Endo International Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Endo International Inc Main Business Overview
13.2.5 Endo International Inc Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 Glenmark Pharmaceuticals Ltd
13.4.1 Glenmark Pharmaceuticals Ltd Company Information
13.4.2 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Glenmark Pharmaceuticals Ltd Main Business Overview
13.4.5 Glenmark Pharmaceuticals Ltd Latest Developments
13.5 Cipla Inc
13.5.1 Cipla Inc Company Information
13.5.2 Cipla Inc Temporal Arteritis Product Portfolios and Specifications
13.5.3 Cipla Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cipla Inc Main Business Overview
13.5.5 Cipla Inc Latest Developments
13.6 Dr Reddy's Laboratories Ltd
13.6.1 Dr Reddy's Laboratories Ltd Company Information
13.6.2 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Portfolios and Specifications
13.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dr Reddy's Laboratories Ltd Main Business Overview
13.6.5 Dr Reddy's Laboratories Ltd Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Temporal Arteritis Product Portfolios and Specifications
13.7.3 Abbott Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 F. Hoffmann -La Roche Ltd
13.8.1 F. Hoffmann -La Roche Ltd Company Information
13.8.2 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Portfolios and Specifications
13.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 F. Hoffmann -La Roche Ltd Main Business Overview
13.8.5 F. Hoffmann -La Roche Ltd Latest Developments
13.9 Pfizer Inc
13.9.1 Pfizer Inc Company Information
13.9.2 Pfizer Inc Temporal Arteritis Product Portfolios and Specifications
13.9.3 Pfizer Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pfizer Inc Main Business Overview
13.9.5 Pfizer Inc Latest Developments
13.10 Zydus Group
13.10.1 Zydus Group Company Information
13.10.2 Zydus Group Temporal Arteritis Product Portfolios and Specifications
13.10.3 Zydus Group Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zydus Group Main Business Overview
13.10.5 Zydus Group Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Temporal Arteritis Product Portfolios and Specifications
13.11.3 Lupin Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 Amorphex Therapeutics Holdings, Inc
13.12.1 Amorphex Therapeutics Holdings, Inc Company Information
13.12.2 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product Portfolios and Specifications
13.12.3 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Amorphex Therapeutics Holdings, Inc Main Business Overview
13.12.5 Amorphex Therapeutics Holdings, Inc Latest Developments
13.13 Bausch Health Companies Inc
13.13.1 Bausch Health Companies Inc Company Information
13.13.2 Bausch Health Companies Inc Temporal Arteritis Product Portfolios and Specifications
13.13.3 Bausch Health Companies Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Bausch Health Companies Inc Main Business Overview
13.13.5 Bausch Health Companies Inc Latest Developments
13.14 Regeneron Pharmaceuticals Inc
13.14.1 Regeneron Pharmaceuticals Inc Company Information
13.14.2 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Portfolios and Specifications
13.14.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Regeneron Pharmaceuticals Inc Main Business Overview
13.14.5 Regeneron Pharmaceuticals Inc Latest Developments
13.15 Astellas Pharma Inc
13.15.1 Astellas Pharma Inc Company Information
13.15.2 Astellas Pharma Inc Temporal Arteritis Product Portfolios and Specifications
13.15.3 Astellas Pharma Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Astellas Pharma Inc Main Business Overview
13.15.5 Astellas Pharma Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Temporal Arteritis Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Temporal Arteritis by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Temporal Arteritis by Country/Region, 2021, 2025 & 2032
2.2 Temporal Arteritis Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.2.3 Temporal Arteritis Sales by Type
2.2.3.1 Global Temporal Arteritis Sales Market Share by Type (2021-2026)
2.2.3.2 Global Temporal Arteritis Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Temporal Arteritis Sale Price by Type (2021-2026)
2.3 Temporal Arteritis Segment by Application
2.3.1 Hospital
2.3.2 Home Care
2.3.3 Other
2.3.4 Temporal Arteritis Sales by Application
2.3.4.1 Global Temporal Arteritis Sale Market Share by Application (2021-2026)
2.3.4.2 Global Temporal Arteritis Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Temporal Arteritis Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Temporal Arteritis Breakdown Data by Company
3.1.1 Global Temporal Arteritis Annual Sales by Company (2021-2026)
3.1.2 Global Temporal Arteritis Sales Market Share by Company (2021-2026)
3.2 Global Temporal Arteritis Annual Revenue by Company (2021-2026)
3.2.1 Global Temporal Arteritis Revenue by Company (2021-2026)
3.2.2 Global Temporal Arteritis Revenue Market Share by Company (2021-2026)
3.3 Global Temporal Arteritis Sale Price by Company
3.4 Key Manufacturers Temporal Arteritis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Temporal Arteritis Product Location Distribution
3.4.2 Players Temporal Arteritis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TEMPORAL ARTERITIS BY GEOGRAPHIC REGION
4.1 World Historic Temporal Arteritis Market Size by Geographic Region (2021-2026)
4.1.1 Global Temporal Arteritis Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Temporal Arteritis Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Temporal Arteritis Market Size by Country/Region (2021-2026)
4.2.1 Global Temporal Arteritis Annual Sales by Country/Region (2021-2026)
4.2.2 Global Temporal Arteritis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Temporal Arteritis Sales Growth
4.4 APAC Temporal Arteritis Sales Growth
4.5 Europe Temporal Arteritis Sales Growth
4.6 Middle East & Africa Temporal Arteritis Sales Growth
5 AMERICAS
5.1 Americas Temporal Arteritis Sales by Country
5.1.1 Americas Temporal Arteritis Sales by Country (2021-2026)
5.1.2 Americas Temporal Arteritis Revenue by Country (2021-2026)
5.2 Americas Temporal Arteritis Sales by Type (2021-2026)
5.3 Americas Temporal Arteritis Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Temporal Arteritis Sales by Region
6.1.1 APAC Temporal Arteritis Sales by Region (2021-2026)
6.1.2 APAC Temporal Arteritis Revenue by Region (2021-2026)
6.2 APAC Temporal Arteritis Sales by Type (2021-2026)
6.3 APAC Temporal Arteritis Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Temporal Arteritis by Country
7.1.1 Europe Temporal Arteritis Sales by Country (2021-2026)
7.1.2 Europe Temporal Arteritis Revenue by Country (2021-2026)
7.2 Europe Temporal Arteritis Sales by Type (2021-2026)
7.3 Europe Temporal Arteritis Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Temporal Arteritis by Country
8.1.1 Middle East & Africa Temporal Arteritis Sales by Country (2021-2026)
8.1.2 Middle East & Africa Temporal Arteritis Revenue by Country (2021-2026)
8.2 Middle East & Africa Temporal Arteritis Sales by Type (2021-2026)
8.3 Middle East & Africa Temporal Arteritis Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Temporal Arteritis
10.3 Manufacturing Process Analysis of Temporal Arteritis
10.4 Industry Chain Structure of Temporal Arteritis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Temporal Arteritis Distributors
11.3 Temporal Arteritis Customer
12 WORLD FORECAST REVIEW FOR TEMPORAL ARTERITIS BY GEOGRAPHIC REGION
12.1 Global Temporal Arteritis Market Size Forecast by Region
12.1.1 Global Temporal Arteritis Forecast by Region (2027-2032)
12.1.2 Global Temporal Arteritis Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Temporal Arteritis Forecast by Type (2027-2032)
12.7 Global Temporal Arteritis Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Temporal Arteritis Product Portfolios and Specifications
13.1.3 Novartis AG Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Endo International Inc
13.2.1 Endo International Inc Company Information
13.2.2 Endo International Inc Temporal Arteritis Product Portfolios and Specifications
13.2.3 Endo International Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Endo International Inc Main Business Overview
13.2.5 Endo International Inc Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 Glenmark Pharmaceuticals Ltd
13.4.1 Glenmark Pharmaceuticals Ltd Company Information
13.4.2 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Glenmark Pharmaceuticals Ltd Main Business Overview
13.4.5 Glenmark Pharmaceuticals Ltd Latest Developments
13.5 Cipla Inc
13.5.1 Cipla Inc Company Information
13.5.2 Cipla Inc Temporal Arteritis Product Portfolios and Specifications
13.5.3 Cipla Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cipla Inc Main Business Overview
13.5.5 Cipla Inc Latest Developments
13.6 Dr Reddy's Laboratories Ltd
13.6.1 Dr Reddy's Laboratories Ltd Company Information
13.6.2 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Portfolios and Specifications
13.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dr Reddy's Laboratories Ltd Main Business Overview
13.6.5 Dr Reddy's Laboratories Ltd Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Temporal Arteritis Product Portfolios and Specifications
13.7.3 Abbott Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 F. Hoffmann -La Roche Ltd
13.8.1 F. Hoffmann -La Roche Ltd Company Information
13.8.2 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Portfolios and Specifications
13.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 F. Hoffmann -La Roche Ltd Main Business Overview
13.8.5 F. Hoffmann -La Roche Ltd Latest Developments
13.9 Pfizer Inc
13.9.1 Pfizer Inc Company Information
13.9.2 Pfizer Inc Temporal Arteritis Product Portfolios and Specifications
13.9.3 Pfizer Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pfizer Inc Main Business Overview
13.9.5 Pfizer Inc Latest Developments
13.10 Zydus Group
13.10.1 Zydus Group Company Information
13.10.2 Zydus Group Temporal Arteritis Product Portfolios and Specifications
13.10.3 Zydus Group Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zydus Group Main Business Overview
13.10.5 Zydus Group Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Temporal Arteritis Product Portfolios and Specifications
13.11.3 Lupin Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 Amorphex Therapeutics Holdings, Inc
13.12.1 Amorphex Therapeutics Holdings, Inc Company Information
13.12.2 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product Portfolios and Specifications
13.12.3 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Amorphex Therapeutics Holdings, Inc Main Business Overview
13.12.5 Amorphex Therapeutics Holdings, Inc Latest Developments
13.13 Bausch Health Companies Inc
13.13.1 Bausch Health Companies Inc Company Information
13.13.2 Bausch Health Companies Inc Temporal Arteritis Product Portfolios and Specifications
13.13.3 Bausch Health Companies Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Bausch Health Companies Inc Main Business Overview
13.13.5 Bausch Health Companies Inc Latest Developments
13.14 Regeneron Pharmaceuticals Inc
13.14.1 Regeneron Pharmaceuticals Inc Company Information
13.14.2 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Portfolios and Specifications
13.14.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Regeneron Pharmaceuticals Inc Main Business Overview
13.14.5 Regeneron Pharmaceuticals Inc Latest Developments
13.15 Astellas Pharma Inc
13.15.1 Astellas Pharma Inc Company Information
13.15.2 Astellas Pharma Inc Temporal Arteritis Product Portfolios and Specifications
13.15.3 Astellas Pharma Inc Temporal Arteritis Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Astellas Pharma Inc Main Business Overview
13.15.5 Astellas Pharma Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Temporal Arteritis Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Temporal Arteritis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 6. Global Temporal Arteritis Sales Market Share by Type (2021-2026)
Table 7. Global Temporal Arteritis Revenue by Type (2021-2026) & ($ million)
Table 8. Global Temporal Arteritis Revenue Market Share by Type (2021-2026)
Table 9. Global Temporal Arteritis Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Temporal Arteritis Sale by Application (2021-2026) & (K Units)
Table 11. Global Temporal Arteritis Sale Market Share by Application (2021-2026)
Table 12. Global Temporal Arteritis Revenue by Application (2021-2026) & ($ million)
Table 13. Global Temporal Arteritis Revenue Market Share by Application (2021-2026)
Table 14. Global Temporal Arteritis Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Temporal Arteritis Sales by Company (2021-2026) & (K Units)
Table 16. Global Temporal Arteritis Sales Market Share by Company (2021-2026)
Table 17. Global Temporal Arteritis Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Temporal Arteritis Revenue Market Share by Company (2021-2026)
Table 19. Global Temporal Arteritis Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Temporal Arteritis Producing Area Distribution and Sales Area
Table 21. Players Temporal Arteritis Products Offered
Table 22. Temporal Arteritis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Temporal Arteritis Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Temporal Arteritis Sales Market Share Geographic Region (2021-2026)
Table 27. Global Temporal Arteritis Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Temporal Arteritis Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Temporal Arteritis Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Temporal Arteritis Sales Market Share by Country/Region (2021-2026)
Table 31. Global Temporal Arteritis Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Temporal Arteritis Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Temporal Arteritis Sales by Country (2021-2026) & (K Units)
Table 34. Americas Temporal Arteritis Sales Market Share by Country (2021-2026)
Table 35. Americas Temporal Arteritis Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 37. Americas Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 38. APAC Temporal Arteritis Sales by Region (2021-2026) & (K Units)
Table 39. APAC Temporal Arteritis Sales Market Share by Region (2021-2026)
Table 40. APAC Temporal Arteritis Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 42. APAC Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 43. Europe Temporal Arteritis Sales by Country (2021-2026) & (K Units)
Table 44. Europe Temporal Arteritis Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 46. Europe Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Temporal Arteritis Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Temporal Arteritis Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Temporal Arteritis
Table 52. Key Market Challenges & Risks of Temporal Arteritis
Table 53. Key Industry Trends of Temporal Arteritis
Table 54. Temporal Arteritis Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Temporal Arteritis Distributors List
Table 57. Temporal Arteritis Customer List
Table 58. Global Temporal Arteritis Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Temporal Arteritis Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Temporal Arteritis Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Temporal Arteritis Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Temporal Arteritis Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Temporal Arteritis Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Temporal Arteritis Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Temporal Arteritis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Temporal Arteritis Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Temporal Arteritis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Temporal Arteritis Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Temporal Arteritis Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Temporal Arteritis Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Temporal Arteritis Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novartis AG Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis AG Temporal Arteritis Product Portfolios and Specifications
Table 74. Novartis AG Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novartis AG Main Business
Table 76. Novartis AG Latest Developments
Table 77. Endo International Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 78. Endo International Inc Temporal Arteritis Product Portfolios and Specifications
Table 79. Endo International Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Endo International Inc Main Business
Table 81. Endo International Inc Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 83. Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Portfolios and Specifications
Table 84. Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Teva Pharmaceutical Industries Ltd Main Business
Table 86. Teva Pharmaceutical Industries Ltd Latest Developments
Table 87. Glenmark Pharmaceuticals Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 88. Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Portfolios and Specifications
Table 89. Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Glenmark Pharmaceuticals Ltd Main Business
Table 91. Glenmark Pharmaceuticals Ltd Latest Developments
Table 92. Cipla Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Inc Temporal Arteritis Product Portfolios and Specifications
Table 94. Cipla Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Cipla Inc Main Business
Table 96. Cipla Inc Latest Developments
Table 97. Dr Reddy's Laboratories Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr Reddy's Laboratories Ltd Temporal Arteritis Product Portfolios and Specifications
Table 99. Dr Reddy's Laboratories Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dr Reddy's Laboratories Ltd Main Business
Table 101. Dr Reddy's Laboratories Ltd Latest Developments
Table 102. Abbott Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 103. Abbott Temporal Arteritis Product Portfolios and Specifications
Table 104. Abbott Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Abbott Main Business
Table 106. Abbott Latest Developments
Table 107. F. Hoffmann -La Roche Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 108. F. Hoffmann -La Roche Ltd Temporal Arteritis Product Portfolios and Specifications
Table 109. F. Hoffmann -La Roche Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. F. Hoffmann -La Roche Ltd Main Business
Table 111. F. Hoffmann -La Roche Ltd Latest Developments
Table 112. Pfizer Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Inc Temporal Arteritis Product Portfolios and Specifications
Table 114. Pfizer Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Pfizer Inc Main Business
Table 116. Pfizer Inc Latest Developments
Table 117. Zydus Group Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 118. Zydus Group Temporal Arteritis Product Portfolios and Specifications
Table 119. Zydus Group Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Zydus Group Main Business
Table 121. Zydus Group Latest Developments
Table 122. Lupin Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 123. Lupin Temporal Arteritis Product Portfolios and Specifications
Table 124. Lupin Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Lupin Main Business
Table 126. Lupin Latest Developments
Table 127. Amorphex Therapeutics Holdings, Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 128. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product Portfolios and Specifications
Table 129. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Amorphex Therapeutics Holdings, Inc Main Business
Table 131. Amorphex Therapeutics Holdings, Inc Latest Developments
Table 132. Bausch Health Companies Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 133. Bausch Health Companies Inc Temporal Arteritis Product Portfolios and Specifications
Table 134. Bausch Health Companies Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Bausch Health Companies Inc Main Business
Table 136. Bausch Health Companies Inc Latest Developments
Table 137. Regeneron Pharmaceuticals Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 138. Regeneron Pharmaceuticals Inc Temporal Arteritis Product Portfolios and Specifications
Table 139. Regeneron Pharmaceuticals Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Regeneron Pharmaceuticals Inc Main Business
Table 141. Regeneron Pharmaceuticals Inc Latest Developments
Table 142. Astellas Pharma Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 143. Astellas Pharma Inc Temporal Arteritis Product Portfolios and Specifications
Table 144. Astellas Pharma Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Astellas Pharma Inc Main Business
Table 146. Astellas Pharma Inc Latest Developments
Table 1. Temporal Arteritis Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Temporal Arteritis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 6. Global Temporal Arteritis Sales Market Share by Type (2021-2026)
Table 7. Global Temporal Arteritis Revenue by Type (2021-2026) & ($ million)
Table 8. Global Temporal Arteritis Revenue Market Share by Type (2021-2026)
Table 9. Global Temporal Arteritis Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Temporal Arteritis Sale by Application (2021-2026) & (K Units)
Table 11. Global Temporal Arteritis Sale Market Share by Application (2021-2026)
Table 12. Global Temporal Arteritis Revenue by Application (2021-2026) & ($ million)
Table 13. Global Temporal Arteritis Revenue Market Share by Application (2021-2026)
Table 14. Global Temporal Arteritis Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Temporal Arteritis Sales by Company (2021-2026) & (K Units)
Table 16. Global Temporal Arteritis Sales Market Share by Company (2021-2026)
Table 17. Global Temporal Arteritis Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Temporal Arteritis Revenue Market Share by Company (2021-2026)
Table 19. Global Temporal Arteritis Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Temporal Arteritis Producing Area Distribution and Sales Area
Table 21. Players Temporal Arteritis Products Offered
Table 22. Temporal Arteritis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Temporal Arteritis Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Temporal Arteritis Sales Market Share Geographic Region (2021-2026)
Table 27. Global Temporal Arteritis Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Temporal Arteritis Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Temporal Arteritis Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Temporal Arteritis Sales Market Share by Country/Region (2021-2026)
Table 31. Global Temporal Arteritis Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Temporal Arteritis Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Temporal Arteritis Sales by Country (2021-2026) & (K Units)
Table 34. Americas Temporal Arteritis Sales Market Share by Country (2021-2026)
Table 35. Americas Temporal Arteritis Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 37. Americas Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 38. APAC Temporal Arteritis Sales by Region (2021-2026) & (K Units)
Table 39. APAC Temporal Arteritis Sales Market Share by Region (2021-2026)
Table 40. APAC Temporal Arteritis Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 42. APAC Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 43. Europe Temporal Arteritis Sales by Country (2021-2026) & (K Units)
Table 44. Europe Temporal Arteritis Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 46. Europe Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Temporal Arteritis Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Temporal Arteritis Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Temporal Arteritis Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Temporal Arteritis Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Temporal Arteritis
Table 52. Key Market Challenges & Risks of Temporal Arteritis
Table 53. Key Industry Trends of Temporal Arteritis
Table 54. Temporal Arteritis Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Temporal Arteritis Distributors List
Table 57. Temporal Arteritis Customer List
Table 58. Global Temporal Arteritis Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Temporal Arteritis Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Temporal Arteritis Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Temporal Arteritis Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Temporal Arteritis Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Temporal Arteritis Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Temporal Arteritis Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Temporal Arteritis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Temporal Arteritis Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Temporal Arteritis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Temporal Arteritis Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Temporal Arteritis Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Temporal Arteritis Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Temporal Arteritis Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novartis AG Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis AG Temporal Arteritis Product Portfolios and Specifications
Table 74. Novartis AG Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novartis AG Main Business
Table 76. Novartis AG Latest Developments
Table 77. Endo International Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 78. Endo International Inc Temporal Arteritis Product Portfolios and Specifications
Table 79. Endo International Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Endo International Inc Main Business
Table 81. Endo International Inc Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 83. Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Portfolios and Specifications
Table 84. Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Teva Pharmaceutical Industries Ltd Main Business
Table 86. Teva Pharmaceutical Industries Ltd Latest Developments
Table 87. Glenmark Pharmaceuticals Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 88. Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Portfolios and Specifications
Table 89. Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Glenmark Pharmaceuticals Ltd Main Business
Table 91. Glenmark Pharmaceuticals Ltd Latest Developments
Table 92. Cipla Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Inc Temporal Arteritis Product Portfolios and Specifications
Table 94. Cipla Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Cipla Inc Main Business
Table 96. Cipla Inc Latest Developments
Table 97. Dr Reddy's Laboratories Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr Reddy's Laboratories Ltd Temporal Arteritis Product Portfolios and Specifications
Table 99. Dr Reddy's Laboratories Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Dr Reddy's Laboratories Ltd Main Business
Table 101. Dr Reddy's Laboratories Ltd Latest Developments
Table 102. Abbott Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 103. Abbott Temporal Arteritis Product Portfolios and Specifications
Table 104. Abbott Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Abbott Main Business
Table 106. Abbott Latest Developments
Table 107. F. Hoffmann -La Roche Ltd Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 108. F. Hoffmann -La Roche Ltd Temporal Arteritis Product Portfolios and Specifications
Table 109. F. Hoffmann -La Roche Ltd Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. F. Hoffmann -La Roche Ltd Main Business
Table 111. F. Hoffmann -La Roche Ltd Latest Developments
Table 112. Pfizer Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Inc Temporal Arteritis Product Portfolios and Specifications
Table 114. Pfizer Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Pfizer Inc Main Business
Table 116. Pfizer Inc Latest Developments
Table 117. Zydus Group Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 118. Zydus Group Temporal Arteritis Product Portfolios and Specifications
Table 119. Zydus Group Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Zydus Group Main Business
Table 121. Zydus Group Latest Developments
Table 122. Lupin Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 123. Lupin Temporal Arteritis Product Portfolios and Specifications
Table 124. Lupin Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Lupin Main Business
Table 126. Lupin Latest Developments
Table 127. Amorphex Therapeutics Holdings, Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 128. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product Portfolios and Specifications
Table 129. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Amorphex Therapeutics Holdings, Inc Main Business
Table 131. Amorphex Therapeutics Holdings, Inc Latest Developments
Table 132. Bausch Health Companies Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 133. Bausch Health Companies Inc Temporal Arteritis Product Portfolios and Specifications
Table 134. Bausch Health Companies Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Bausch Health Companies Inc Main Business
Table 136. Bausch Health Companies Inc Latest Developments
Table 137. Regeneron Pharmaceuticals Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 138. Regeneron Pharmaceuticals Inc Temporal Arteritis Product Portfolios and Specifications
Table 139. Regeneron Pharmaceuticals Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Regeneron Pharmaceuticals Inc Main Business
Table 141. Regeneron Pharmaceuticals Inc Latest Developments
Table 142. Astellas Pharma Inc Basic Information, Temporal Arteritis Manufacturing Base, Sales Area and Its Competitors
Table 143. Astellas Pharma Inc Temporal Arteritis Product Portfolios and Specifications
Table 144. Astellas Pharma Inc Temporal Arteritis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Astellas Pharma Inc Main Business
Table 146. Astellas Pharma Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Temporal Arteritis
Figure 2. Temporal Arteritis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Temporal Arteritis Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Temporal Arteritis Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Temporal Arteritis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Temporal Arteritis Sales Market Share by Country/Region (2025)
Figure 10. Temporal Arteritis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Parenteral
Figure 13. Global Temporal Arteritis Sales Market Share by Type in 2026
Figure 14. Global Temporal Arteritis Revenue Market Share by Type (2021-2026)
Figure 15. Temporal Arteritis Consumed in Hospital
Figure 16. Global Temporal Arteritis Market: Hospital (2021-2026) & (K Units)
Figure 17. Temporal Arteritis Consumed in Home Care
Figure 18. Global Temporal Arteritis Market: Home Care (2021-2026) & (K Units)
Figure 19. Temporal Arteritis Consumed in Other
Figure 20. Global Temporal Arteritis Market: Other (2021-2026) & (K Units)
Figure 21. Global Temporal Arteritis Sale Market Share by Application (2025)
Figure 22. Global Temporal Arteritis Revenue Market Share by Application in 2026
Figure 23. Temporal Arteritis Sales by Company in 2026 (K Units)
Figure 24. Global Temporal Arteritis Sales Market Share by Company in 2026
Figure 25. Temporal Arteritis Revenue by Company in 2026 ($ millions)
Figure 26. Global Temporal Arteritis Revenue Market Share by Company in 2026
Figure 27. Global Temporal Arteritis Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Temporal Arteritis Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Temporal Arteritis Sales 2021-2026 (K Units)
Figure 30. Americas Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 31. APAC Temporal Arteritis Sales 2021-2026 (K Units)
Figure 32. APAC Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 33. Europe Temporal Arteritis Sales 2021-2026 (K Units)
Figure 34. Europe Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Temporal Arteritis Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 37. Americas Temporal Arteritis Sales Market Share by Country in 2026
Figure 38. Americas Temporal Arteritis Revenue Market Share by Country (2021-2026)
Figure 39. Americas Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 40. Americas Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 41. United States Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Temporal Arteritis Sales Market Share by Region in 2026
Figure 46. APAC Temporal Arteritis Revenue Market Share by Region (2021-2026)
Figure 47. APAC Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 48. APAC Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 49. China Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 53. India Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Temporal Arteritis Sales Market Share by Country in 2026
Figure 57. Europe Temporal Arteritis Revenue Market Share by Country (2021-2026)
Figure 58. Europe Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 59. Europe Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 60. Germany Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 61. France Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Temporal Arteritis Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 68. Egypt Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Temporal Arteritis in 2026
Figure 74. Manufacturing Process Analysis of Temporal Arteritis
Figure 75. Industry Chain Structure of Temporal Arteritis
Figure 76. Channels of Distribution
Figure 77. Global Temporal Arteritis Sales Market Forecast by Region (2027-2032)
Figure 78. Global Temporal Arteritis Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Temporal Arteritis Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Temporal Arteritis Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Temporal Arteritis Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Temporal Arteritis Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Temporal Arteritis
Figure 2. Temporal Arteritis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Temporal Arteritis Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Temporal Arteritis Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Temporal Arteritis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Temporal Arteritis Sales Market Share by Country/Region (2025)
Figure 10. Temporal Arteritis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Parenteral
Figure 13. Global Temporal Arteritis Sales Market Share by Type in 2026
Figure 14. Global Temporal Arteritis Revenue Market Share by Type (2021-2026)
Figure 15. Temporal Arteritis Consumed in Hospital
Figure 16. Global Temporal Arteritis Market: Hospital (2021-2026) & (K Units)
Figure 17. Temporal Arteritis Consumed in Home Care
Figure 18. Global Temporal Arteritis Market: Home Care (2021-2026) & (K Units)
Figure 19. Temporal Arteritis Consumed in Other
Figure 20. Global Temporal Arteritis Market: Other (2021-2026) & (K Units)
Figure 21. Global Temporal Arteritis Sale Market Share by Application (2025)
Figure 22. Global Temporal Arteritis Revenue Market Share by Application in 2026
Figure 23. Temporal Arteritis Sales by Company in 2026 (K Units)
Figure 24. Global Temporal Arteritis Sales Market Share by Company in 2026
Figure 25. Temporal Arteritis Revenue by Company in 2026 ($ millions)
Figure 26. Global Temporal Arteritis Revenue Market Share by Company in 2026
Figure 27. Global Temporal Arteritis Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Temporal Arteritis Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Temporal Arteritis Sales 2021-2026 (K Units)
Figure 30. Americas Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 31. APAC Temporal Arteritis Sales 2021-2026 (K Units)
Figure 32. APAC Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 33. Europe Temporal Arteritis Sales 2021-2026 (K Units)
Figure 34. Europe Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Temporal Arteritis Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Temporal Arteritis Revenue 2021-2026 ($ millions)
Figure 37. Americas Temporal Arteritis Sales Market Share by Country in 2026
Figure 38. Americas Temporal Arteritis Revenue Market Share by Country (2021-2026)
Figure 39. Americas Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 40. Americas Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 41. United States Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Temporal Arteritis Sales Market Share by Region in 2026
Figure 46. APAC Temporal Arteritis Revenue Market Share by Region (2021-2026)
Figure 47. APAC Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 48. APAC Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 49. China Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 53. India Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Temporal Arteritis Sales Market Share by Country in 2026
Figure 57. Europe Temporal Arteritis Revenue Market Share by Country (2021-2026)
Figure 58. Europe Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 59. Europe Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 60. Germany Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 61. France Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Temporal Arteritis Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Temporal Arteritis Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Temporal Arteritis Sales Market Share by Application (2021-2026)
Figure 68. Egypt Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Temporal Arteritis Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Temporal Arteritis in 2026
Figure 74. Manufacturing Process Analysis of Temporal Arteritis
Figure 75. Industry Chain Structure of Temporal Arteritis
Figure 76. Channels of Distribution
Figure 77. Global Temporal Arteritis Sales Market Forecast by Region (2027-2032)
Figure 78. Global Temporal Arteritis Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Temporal Arteritis Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Temporal Arteritis Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Temporal Arteritis Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Temporal Arteritis Revenue Market Share Forecast by Application (2027-2032)
